Rheumatic Disease Patients Offer Clues to Long COVID Driver miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
In about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year period. The findings represent an "underappreciated, persistent phenotype."
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients with rheumatic disease.
May 11 will mark the end of the 3-year COVID-19 national public health emergency, as announced earlier this year by President Joe Biden and HHS. In the immediate short-term, this will mean the end of free laboratory and over the counter COVID-19 tests, depending on patients’ individual insurance or Medicare status. Facilities will no longer have the ability to rapidly increase capacity in